Physician profile
Abdullah M Yonan
NPI 1255324182
$7,311.20
in general payments reported to CMS, 2019-2025
36 companies · $2,931 in 2025
The $2,931 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $615 · 2020: $151 · 2021: $360 · 2022: $553 · 2023: $1,031 · 2024: $1,672 · 2025: $2,931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,534 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,533.96 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,396.67 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $991.51 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $847.91 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $695.42 | 2024-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $601.16 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Actelion Pharmaceuticals US, INC. | $249.36 | 2019-2025 | Opsumit, Uptravi |
| Insmed, INC. | $248.24 | 2023-2025 | Arikayce, Brinsupri |
| Electromed, INC. | $231.11 | 2022-2025 | Smartvest |
| Genentech USA, INC. | $226.69 | 2019-2025 | Xolair |
| United Therapeutics Corporation | $226.05 | 2019-2025 | Tyvaso, Tyvaso |
| Amgen INC. | $171.85 | 2024-2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $148.90 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $138.82 | 2023-2024 | Glassia |
| Philips North America LLC | $112.30 | 2019-2025 | Dreamwear, (8874) Incourage |
| Sanofi-Aventis U.S. LLC | $98.99 | 2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $89.25 | 2023-2025 | Inspire |
| Mylan Specialty L.P. | $87.92 | 2019-2024 | Yupelri |
| Verona Pharma, INC. | $87.60 | 2025 | Ohtuvayre |
| Inogen, INC. | $64.07 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Grifols USA, LLC | $62.69 | 2020-2024 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $57.72 | 2023-2024 | Wakix |
| Sunovion Pharmaceuticals INC. | $55.31 | 2019-2021 | |
| Baxter Healthcare | $54.05 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Viatris Specialty LLC | $51.89 | 2025 | Yupelri |
| Covis Pharma Gmbh | $51.50 | 2021 | |
| Pfizer INC. | $41.49 | 2024-2025 | |
| Shire North American Group INC | $36.74 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.82 | 2022-2023 | Xifaxan, Trulance |
| Lucid Diagnostics INC. | $29.86 | 2022 | |
| Advanced Respiratory, INC | $28.82 | 2021 | |
| Merck Sharp & Dohme LLC | $20.64 | 2022 | |
| Lilly USA, LLC | $16.73 | 2025 | Zepbound |
| Orthofix Medical, INC. | $16.70 | 2024 | Physio-Stim |
| Abbott Laboratories | $13.21 | 2023 | Eterna |
| Tactile Systems Technology INC | $12.95 | 2023 | Flexitouch Plus, Entre Plus |
| Phadia US INC. | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdullah Yonan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.